The EPS projection of Lannett Co Inc (NYSE:LCI) for period quarter completed 2016-12-31 is $0.85.
The EPS estimates pronounced a week and 30 days ago were $0.85 and $0.85 correspondingly. The EPS forecasts specified 60 and 90 days before were $0.85 and $0.85 respectively. From a week ago, the aberration in EPS forecast is 0 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 4 is $0.85 based on 5 EPS estimations. The EPS stated on 2016-08-23 was $0.73. The EPS surprise was $0.13, or 21.67 percent. The standard deviation as per known EPS estimates was $0.05.
The positive EPS revisions were 0 a week earlier and negative revisions were 0. In last 30 and 60 days, the positive EPS revisions were 0 and 2 correspondingly, while for 90 and 120 days, revisions count was 2 and 2.
The negative revisions of per-share earnings in the last 30 and 60-days were 0 and 0 in that order. however, for 90 and 120 days’ period, the count was 0 and 0 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 0 and 0 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of Lannett Co Inc (NYSE:LCI) is $178.976 and the median was $179.25. The estimate is stated by 5 analysts for the fiscal 2017.
The highest annual projection is $181.5 and lowest sales target is $176.63. This marks a standard deviation of $2.091.
Almost 5 have given revised positive sales forecast in the past week and 5 have downgraded forecasts. As per the stated estimates, the change in target from the past week is 0 percent.
Nearly 5 have revised sales projections in positive side over the past month and 5 have downgraded forecasts. This shows a mean estimate deviation of 0 percent.
Just about 5 have revised sales forecast on plus side over the quarter and 5 have downgraded forecasts. This shows mean estimate deviation of -1.52 percent.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...